menu
    • menu

    Company profile for NovaBridge Biosciences

    NEW Drugs in Dev: 16
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NovaBridge Biosciences bridges scientific discovery and clinical application by developing innovative biopharmaceutical solutions. The company emphasizes collaboration, advanced research, and scalable technologies to accelerate the delivery of effective therapies to patients worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NovaBridge BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2440 Research Blvd, Suite 400 Rockville, MD 20850
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.novabridge.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NovaBridge to Present at Jefferies Global Healthcare
    NovaBridge to Present at Jefferies Global Healthcare

    28 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/28/3302657/0/en/novabridge-to-present-at-the-2026-jefferies-global-healthcare-conference.html

    GLOBENEWSWIRE
    28 May 2026
    Share Share
    Novabridge Reports 2025 Financial Results, Business Update
    Novabridge Reports 2025 Financial Results, Business Update

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269679/0/en/NovaBridge-Reports-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    NovaBridge Announces Productive FDA Type B Meeting
    NovaBridge Announces Productive FDA Type B Meeting

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256129/0/en/NovaBridge-Announces-Productive-FDA-Type-B-Meeting-on-Potential-Accelerated-Approval-Pathway-for-Givastomig-in-Gastric-Cancer.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Novabridge To Present At Global Healthcare Conference
    Novabridge To Present At Global Healthcare Conference

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247232/0/en/NovaBridge-to-Present-at-the-Leerink-Partners-2026-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    NovaBridge Doses First in Ph2 Givastomig Study
    NovaBridge Doses First in Ph2 Givastomig Study

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239738/0/en/NovaBridge-Doses-First-Patient-in-Global-Randomized-Phase-2-Study-of-Givastomig-Combined-with-Immunochemotherapy-in-Patients-with-1L-Metastatic-Gastric-Cancer.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    NovaBridge Chairman Fu Wei Announces Open Market Purchases
    NovaBridge Chairman Fu Wei Announces Open Market Purchases

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221551/0/en/NovaBridge-Announces-Open-Market-Purchases-by-Executive-Chairman-Fu-Wei.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search